Zobrazeno 1 - 10
of 277
pro vyhledávání: '"Bayard L. Powell"'
Autor:
James S. Blachly, Uma Borate, Eunice S. Wang, Bhavana Bhatnagar, Ross L. Levine, Ann-Kathrin Eisfeld, Amy Burd, John C. Byrd, Richard Stone, Brian J. Druker, Alice S. Mims, Krzysztof Mrόzek, Eytan M. Stein, Bayard L. Powell, Jonathan E. Kolitz, Clara D. Bloomfield, Shelley Orwick, Jessica Kohlschmidt, Dimitrios Papaioannou, Deedra Nicolet
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-15 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Older patients (≥ 60 years) with acute myeloid leukemia (AML) often have multiple, sequentially acquired, somatic mutations that drive leukemogenesis and are associated with poor outcome. Beat AML is a Leukemia and Lymphoma Society-spons
Autor:
Susan Lyerly, Megan Manuel, Rupali Bhave, Leslie R. Ellis, Ryan Woods, Timothy S. Pardee, Mary Beth Seegars, Bayard L. Powell, Dianna S. Howard, Sarah Dralle
Publikováno v:
Journal of Hematology
Background: Resistance to therapy and a poor outcome characterize relapsed or refractory acute myeloid leukemia (AML). There is a clear need for additional palliative approaches with acceptable toxicities. Vincristine sulfate liposome injection (VSLI
Autor:
Rupali Bhave, Ann M. Geiger, Kah Poh Loh, Jeff D Williamson, Timothy S. Pardee, Heidi D. Klepin, Mohammed Saad, Janet A. Tooze, Stephen B. Kritchevsky, Bayard L. Powell, Leslie R. Ellis
Publikováno v:
Blood
Autor:
Boris Pasche, Stefan C. Grant, Stacey S O'Neill, Ping Chieh Chou, Jimmy Ruiz, Bayard L. Powell, William J. Petty, Umit Topaloglu, Martha A. Alexander-Miller, Reginald F. Munden, Ralph B. D'Agostino, Tamjeed Ahmed, Wei Zhang, Thomas Lycan, Lance D. Miller, Liang Liu, Gregory A. Hawkins
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 15, Iss 2, Pp 462-472 (2021)
Molecular Oncology, Vol 15, Iss 2, Pp 462-472 (2021)
In this work, we study the survival outcomes of patients with lung adenocarcinoma in four independent cohorts. By classifying patients with KRAS mutations into three subgroups based on their mutation status of TP53 and SMARCA4, our analysis indicates
Autor:
Bayard L. Powell, Kieron Dunleavy, Michelle A. Fanale, Philip J. Bierman, David Peace, Andrea Nicole Lucas, Jeremy S. Abramson, Wyndham H. Wilson, Christopher Melani, Stefania Pittaluga, Peter R. Watson, Seth M. Steinberg, Wahid Hanna, Brad S. Kahl, Elaine S. Jaffe, Mark Roschewski, Brian K. Link, Nancy L. Bartlett, Richard F. Little, Ariela Noy, Deepa Jagadeesh, Jonathan W. Friedberg, Prapti A. Patel, Ronald T. Mitsuyasu
Publikováno v:
J Clin Oncol
PURPOSE Burkitt lymphoma is an aggressive B-cell lymphoma curable with dose-intensive chemotherapy derived from pediatric leukemia regimens. Treatment is acutely toxic with late sequelae. We hypothesized that dose-adjusted etoposide, doxorubicin, cyc
Autor:
R.L. Bayer, Jerald P. Radich, Maria Brown, M. Lynn Savoie, Bruno C. Medeiros, Harry P. Erba, John M. Pagel, Selina M. Luger, Stephen A. Strickland, Sanjay R. Mohan, Guillermo Garcia-Manero, Dennis L. Confer, David A. Rizzieri, Stephen R. Spellman, Richard Stone, Geoffrey L. Uy, David F. Claxton, Mark R. Litzow, Min Fang, Frederick R. Appelbaum, Megan Othus, Mikkael A. Sekeres, Jeffrey Chell, Bayard L. Powell, James Essell, Guido Marcucci, Anna Moseley, Richard A. Larson, Tara L. Lin
Publikováno v:
JCO Oncol Pract
PURPOSE: Patients with acute myeloid leukemia with high-risk cytogenetics in first complete remission (CR1) achieve better outcomes if they undergo allogeneic hematopoietic cell transplantation (HCT) compared with consolidation chemotherapy alone. Ho
Autor:
Barbara J. Nicklas, Timothy S. Pardee, Bayard L. Powell, Leslie R. Ellis, Jeff D. Williamson, Kah Poh Loh, Stephen B. Kritchevsky, Neha G. Goyal, Janet A. Tooze, Heidi D. Klepin
Publikováno v:
J Geriatr Oncol
OBJECTIVES: To investigate changes in inflammatory biomarkers during induction therapy for older adults with acute myeloid leukemia (AML) and their associations with geriatric assessment (GA) measures and outcomes. METHODS: This was a single institut
Autor:
Timothy S. Pardee, Alok Uprety, Janet A. Tooze, Sarah Dralle, Samuel J. Yates, Megan Manuel, Susan Lyerly, Bayard L. Powell, Heidi D. Klepin
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 7, Pp 2403-2413 (2020)
Cancer Medicine, Vol 9, Iss 7, Pp 2403-2413 (2020)
Standardized phase angle (SPhA) is a tool used to estimate body composition and cell membrane integrity. Standardized phase angle has been shown to predict survival in solid malignancies and hematopoietic stem cell transplant patients. We investigate
Autor:
Geoffrey L. Uy, Maria R. Baer, Wendy Stock, Weiqiang Zhao, Ellen K. Ritchie, Richard A. Larson, Jennifer Le-Rademacher, Heidi D. Klepin, Richard Stone, Susan A. Geyer, Ben L. Sanford, Karla V. Ballman, Drew K. Seisler, Libby Storrick, Bayard L. Powell, Guido Marcucci, Brittny Major-Elechi, Harvey J. Cohen
Publikováno v:
J Geriatr Oncol
Objective To demonstrate feasibility of performing geriatric assessment (GA) in the National Clinical Trials Network (NCTN) and to explore the utility of GA to characterize treatment tolerance. Materials and methods We conducted a multisite companion
Autor:
Jessica Kohlschmidt, Richard Stone, Dimitrios Papaioannou, Clara D. Bloomfield, Adrienne M. Dorrance, Marius Bill, Bayard L. Powell, Andrew J. Carroll, Deedra Nicolet, Jonathan E. Kolitz, Ramiro Garzon, John C. Byrd, Ann-Kathrin Eisfeld, Zachary Brannan, Xiaoqing Rong-Mullins, Krzysztof Mrózek, Kellie J. Archer, Christopher J. Walker
Publikováno v:
Haematologica
Leukemia stem cells (LSC) are more resistant to standard chemotherapy and their persistence during remission can cause relapse, which is still one of the major clinical challenges in the treatment of acute myeloid leukemia (AML). A better understandi